ArticleTheranostics2021

Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.

Yanli Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.